Onco-Innovations Limited Stock: price and insider trades · Canada

This page follows insider dealings at Onco-Innovations Limited as filed with SEDI, a company from the Health Care sector. From 21 October 2025 to 21 October 2026, the disclosure feed for Onco-Innovations Limited logged 47 filings by 8 insiders.

Open-market activity splits into 2 purchases and 3 sales totalling €20k; 1 insider sit on the buying side and 2 insiders on the selling side. The totals do not cover 2 filings with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Those buying include 1 senior executive. At €8,896, the sale published on 13 August 2026 by Novak, Stephen Michael is the largest of the period (0.052% of market cap).

For context, the typical company on the same exchange (median of 2,126 companies) published 12 filings over the same period, against 47 filings here. Looking back to 2026, when coverage begins, insiders filed 2 purchases and 3 sales.

The last purchase on record was published on 18 June 2026, which is 124 days ago. Typically, a trade is published a median of 1 day after it takes place. The shorter that gap, the sooner other investors can see what insiders have done. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.

For comparison within the same sector, see the insider buying recorded at MAIA Biotechnology, Inc. and Cooper Companies, Inc. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.